Metronidazol Braun

Metronidazole, the active ingredient in Metronidazol Braun, is a nitroimidazole antibiotic presented as an injection for intravenous use. It treats anaerobic bacterial infections and certain protozoal diseases in adults and children as prescribed.

GNH USA supplies Metronidazol Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is indicated for infections caused by anaerobic bacteria and susceptible protozoa. - Anaerobic bacterial infections: effective in treating intra‑abdominal, pelvic and skin‑soft tissue infections caused by susceptible anaerobes. - Bacterial vaginosis: restores normal vaginal flora by eliminating Gardnerella and other anaerobes. - Trichomoniasis: eradicates Trichomonas vaginalis infection in the genitourinary tract. - Amoebiasis: treats intestinal and extra‑intestinal infection caused by Entamoeba histolytica. - Pelvic inflammatory disease: reduces polymicrobial infection involving anaerobes in the upper genital tract.

Metronidazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Metallic taste: transient alteration of taste perception. - Headache: mild to moderate cephalic discomfort. - Diarrhea: loose stools, usually self‑limiting.

Serious or Rare Side Effects: - Seizures: rare neurologic event requiring immediate medical attention. - Peripheral neuropathy: numbness or tingling in extremities, may be irreversible. - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Hepatotoxicity: elevated liver enzymes or jaundice indicating liver injury.

Before using Metronidazol Braun, clinicians should consider several safety precautions. - Pregnancy: Category B, use only if benefits outweigh potential risks. - Alcohol interaction: avoid alcohol during treatment and for at least 48 hours after to prevent disulfiram‑like reaction. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Hepatic disease: monitor liver function tests during prolonged therapy. - Neurologic symptoms: discontinue if seizures, neuropathy, or encephalopathy develop. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Metronidazol Braun can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Alcohol: concurrent intake can cause severe flushing, tachycardia, and nausea. - Warfarin: may increase anticoagulant effect, raising bleeding risk. - Lithium: co‑administration can raise lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma concentrations. - Phenobarbital: may reduce metronidazole levels, decreasing effectiveness. - Oral contraceptives: possible reduction in contraceptive efficacy, advise backup method.